Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

CTP-543 is generally safe for treating alopecia areata.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Clinical trials for hair loss in the USA show differences in participation among different races and ethnic groups.

Baricitinib shows promise in treating severe hair loss.

Longer TA repeats in the SRD5A2 gene may increase acne risk in Chinese people.

Farudodstat may effectively treat alopecia areata without harmful side effects.

SNP rs2479106 in the DENND1A gene may increase PCOS risk in Saudi Arabian females.

Finasteride helps female-pattern hair loss.

Certain changes in the SHBG gene may increase the risk of PCOS in Iraqi women.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

A new genetic variant causes trichothiodystrophy in two brothers, but their mother may carry it without showing symptoms.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

A Chinese man with KID syndrome had a new mutation in the GJB2 gene.

The lotion helps manage mild to moderate hair loss.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

The S9 fraction with GC-IDMS is effective for measuring 5α-reductase activity.